Results
Title

Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us combat SARS-CoV-2.

Authors

Nabavi, Seyed Fazel; Habtemariam, Solomon; Clementi, Emilio; Berindan-Neagoe, Ioana; Cismaru, Cosmin Andrei; Rasekhian, Mahsa; Banach, Maciej; Izadi, Morteza; Bagheri, Mahdi; Bagheri, Mohammad Sadegh; Nabavi, Seyed Mohammad

Subjects

UNITED States. Food & Drug Administration; SARS virus; VIRAL envelope proteins; MERS coronavirus; COVID-19; KINASE inhibitors; AVIAN infectious bronchitis virus; SARS-CoV-2

Publication

Archives of Medical Science, 2020, Vol 16, Issue 4, p519

ISSN

1734-1922

Publication type

Academic Journal

DOI

10.5114/aoms.2020.94504